Piper Sandler lowered the firm’s price target on Ultragenyx (RARE) to $115 from $140 and keeps an Overweight rating on the shares after analyst ...
Piper Sandler analyst David Amsellem lowered the firm’s price target on Amphastar (AMPH) to $32 from $36 and keeps a Neutral rating on the ...
Hosted on MSN1mon
Piper Sandler cuts Regeneron stock target to $1,013On Monday, Piper Sandler adjusted its price target for ... Despite this, UBS acknowledged Regeneron's promising pipeline, which includes potential treatments for obesity and severe food allergies.
marketers can hire Piper the AI SDR as an always-on SDR agent to convert leads at scale. B2B Marketers’ Reliance on Human SDRs Leaves Pipeline on the Table Prior to AI SDR availability ...
Piper Sandler downgraded Sutro Biopharma (STRO) to Neutral from Overweight with a price target of $2, down from $8. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results